Alzheimer disease and subcortical ischemic vascular dementia: Evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging

Radiology

Volumn 198, Issue 2, 1996, Pages 537-545

  MacKay, Shane ^a,c   Ezekiel, Frank ^c   Sclafani, Victoria Di ^c   Meyerhoff, Dieter J ^a,b   Gerson, Jack ^a,b,c   Norman, David ^b   Fein, George ^c   Weiner, Michael W ^a,b,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain, ischemia; Brain, metabolism; Dementia; Magnetic resonance (MR), spectroscopy

Indexed keywords

ASPARTIC ACID DERIVATIVE; CHOLINE DERIVATIVE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0030051604     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.198.2.8596863     Document Type: Article

References (33)

1. Murphy DG, DeCarli CD, Daly E, et al. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type. correlations with disease severity. Biol Psychiatry 1993; 4:612-621.
2. Jernigan TL, Salmon DP, Butters N, Hesselink JR Cerebral structure on MRI. II Specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry 1991, 29:68-81.
3. Wahlund LO, Andersson-Lundman G, Basun H, et al. Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects. Magn Reson Imaging 1993; 11:169-174.
4. Schmidt R. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992, 32:164-169.
5. McDonald WM, Krishnan KR, Doraiswamy PM, et al. Magnetic resonance findings in patients with early-onset Alzheimer's disease. Biol Psychiatry 1991; 29:799-810.
6. Sullivan EV, Shear PK, Mathalon DH, et al Greater abnormalities of brain cerebral spinal fluid volumes in younger than in older patients with Alzheimer's disease. Arch Neurol 1993, 50:359-373.
7. Luxenbcrg JS, Haxby JV, Creasey H, Sundaram M, Rapoport SI. Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. Neurology 1987; 37:1135-1140.
8. Davis PC, Gearing M, Gray L, et al. The CERAD experience, VIII. Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology 1995; 45:178-179
9. Ikeda M, Tanabe H, Nakagawa Y, et al. I-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease. Neuroradiology 1994; 36.7-10.
10. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991; 41:51-54.
11. Biegon A, Eberling JL, Richardson BC, et al Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study. Neurobiol Aging 1994; 15 393-397
12. Vermersch P, Scheltens P, Barkhof F, Steinling M, Leys D. Evidence for atrophy of the corpus callosum in Alzheimer's disease Eur Neurol 1994; 34-83-86.
13. Rusinek H, de Leon MJ, George AE, et al Alzheimer disease measuring loss of cerebral gray matter with MR imaging. Radiology 1991; 178:109-114.
14. Kawamura J, Meyer JS, Ichijo M, Kobari M, Terayama Y, Weathers S. Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. J Neurol Neurosurg Psychiatry 1993; 56:182-187.
15. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia. J Am Geriatr Soc 1992; 40:375-380.
16. Kobari M, Meyer JS, Ichijo M. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging. Arch Neurol 1990, 47:161-165.
17. Leuchter AF, Dunkin JJ, Lufkin RB, Anzai Y, Cook IA, Newton TF. Effect of white matter disease on functional connections in the aging brain. J Neurol Neurosurg Psychiatry 1994; 57:1347-1354.
18. Kwo-On-Yuen PF, Newmark RD, Bolo N, Jagust WJ, Roos MS. Regional correlation of N-acetyl-L-aspartic concentration with severity of dementia in Alzheimer's Disease (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1991. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1991; 429.
19. Klunk WE, Panchalingam K, Moossy J, McClure RJ, Pettegrew JW. N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study. Neurology 1992; 42:1578-1585.
20. Shiino A, Matsuda M, Morikawa S, Inubushi T, Akiguchi I, Handa J. Proton magnetic resonance spectroscopy with dementia. Surg Neurol 1993; 39:143-147.
21. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994; 32:110-115.
22. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993; 187:433-437.
23. 1H metabolites (abstr). In Book of abstracts. Society of Magnetic Resonance in Medicine 1992. Berkely, Calif: Society of Magnetic Resonance in Medicine, 1992; 1931.
24. Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton spectroscopic imaging Ann Neurol 1994; 36:40-47.
25. 1H metabolites (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1994. Berkeley, Calif. Society of Magnetic Resonance in Medicine, 1994; 597.
26. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992, 42:473-480
27. Folstein MF, Folstein SE, McHugh PR Mini-mental state. J Psychiatric Res 1975; 12:189-198.
28. Maudsley AA, Lin E, Weiner MW. Spectroscopic imaging display and analysis Magn Reson Imaging 1991; 10:471-485
29. Lim K, Pfefferbaum A Segmentation of MR brain images into cerebrospinal fluid spaces, white and grey matter. J Comput Assist Tomogr 1989; 13:588-593.
30. Di Sclafani V, Ezekiel E, Meyerhoff DJ, et al. Brain atrophy and brain function in older abstinent alcoholic men. Alcohol Clin Exp Res 1995, 19:1121-1126.
31. Mardia KV, Kent JT, Bibby JM. Multivariate analysis. London, England: Academic Press, 1979; chapter 11.
32. 1H-magnetic resonance spectroscopic imaging. Magn Reson Med 1995; 33:127-133.
33. Doyle TJ, Bedell BJ, Narayana PA. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain. Magn Reson Med 1995; 33:755-759.